CAVALIERE, Giovanni
CAVALIERE, Giovanni
SCIENZE MEDICHE
A traveller's wart: tungiasis
2018-01-01 Fava, Paolo; Astrua, Chiara; Brizio, Matteo; Cavaliere, Giovanni; Senetta, Rebecca; Fierro, Maria Teresa; Quaglino, Pietro
Chronic Pruritus in Atopic Patients Treated with Dupilumab: Real Life Response and Related Parameters in 354 Patients
2022-01-01 Mastorino, Luca; Rosset, François; Gelato, Federica; Ortoncelli, Michela; Cavaliere, Giovanni; Quaglino, Pietro; Ribero, Simone
Complete regression of melanoma skin metastases after electrochemotherapy plus ipilimumab treatment: An unusual clinical presentation
2015-01-01 Brizio, Matteo; Fava, Paolo; Astrua, Chiara; Cavaliere, Giovanni; Savoia, Paola
Dermatological approach to vemurafenib skin toxicity: a single centre experience
2016-01-01 Fava, Paolo; Marra, Elena; Astrua, Chiara; Brizio, Matteo; Cavaliere, Giovanni; Quaglino, Pietro; Fierro, Maria T; Savoia, Paola
Dose reduction of dupilumab in atopic patients with controlled atopic dermatitis: A safe and effective practice?
2023-01-01 Mastorino, Luca; Gelato, Federica; Richiardi, Irene; Cavaliere, Giovanni; Quaglino, Pietro; Ortoncelli, Michela; Ribero, Simone
Dupilumab induces a rapid decrease of pruritus in adolescents: A pilot real-life study
2021-01-01 Mastorino L.; Viola R.; Panzone M.; Avallone G.; Gallo G.; Ortoncelli M.; Cavaliere G.; Quaglino P.; Ribero S.
Epidemiologia, diagnosi clinica e patologica
2018-01-01 Pietro QUaglino, Giovanni Cavaliere, Rebecca Senetta, Simone Ribero, Franco PIcciotto
Herpes Zoster Infection in Atopic Patients Undergoing Upadacitinib: Practical Suggestions on Vaccination and Management
2023-01-01 Ortoncelli, Michela; Mastorino, Luca; Gelato, Federica; Richiardi, Irene; Cavaliere, Giovanni; Quaglino, Pietro; Ribero, Simone
Identification of risk factors for multiple non-melanoma skin cancers in italian kidney transplant recipients
2019-01-01 Zavattaro E.; Fava P.; Veronese F.; Cavaliere G.; Ferrante D.; Cantaluppi V.; Ranghino A.; Biancone L.; Fierro M.T.; Savoia P.
Impact of comorbidities in the response of atopic patients treated with dupilumab: a real-life study up to 36 weeks
2022-01-01 Mastorino, L; Cantafio Duò, V L; Vecco, C; Gelato, F; Giordano, S; Roccuzzo, G; Cavaliere, G; Avallone, G; Ortoncelli, M; Ribero, S; Quaglino, P
Intestinal involvement in toxic epidermal necrolysis. A case report and review of literature.
2014-01-01 Fava, P; Astrua, C; Cavaliere, G; Brizio, M; Savoia, P; Quaglino, P; Fierro, Mt1.
Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
2023-01-01 Gelato, Federica; Mastorino, Luca; Stepkina, Ekaterina; Cavaliere, Giovanni; Ribero, Simone; Quaglino, Pietro; Ortoncelli, Michela
Long-Term Efficacy and Safety of Dupilumab in Patients with Atopic Dermatitis: A Single-Centre Retrospective Study
2023-01-01 Ortoncelli, M; Macagno, N; Mastorino, L; Gelato, F; Richiardi, I; Cavaliere, G; Quaglino, P; Ribero, S
Mogamulizumab associated crusted scabies: a rare diagnostic confounder
2024-01-01 GIUNIPERO DI CORTERANZO, Isotta; ROCCUZZO, Gabriele; CRESPI, Orsola; CAVALIERE, Giovanni; FAVA, Paolo; RIBERO, Simone; QUAGLINO, Pietro
Ocular Adverse Events in Patients With Atopic Dermatitis Treated With Upadacitinib: A Real-Life Experience
2023-01-01 Gelato, Federica; Mastorino, Luca; Quaglino, Pietro; Cavaliere, Giovanni; Ortoncelli, Michela; Ribero, Simone
Onset of multiple sclerosis in a patient on dupilumab therapy for atopic dermatitis: A case report
2022-01-01 Gelato, Federica; Mastorino, Luca; Cavalla, Paola; Quaglino, Pietro; Cavaliere, Giovanni; Vercellino, Marco; Bosa, Chiara; Inglese, Matilde; De Palma, Raffaele; Ortoncelli, Michela; Ribero, Simone
Predisposition to conjunctivitis and male sex reduces drug survival of dupilumab in adults and adolescents
2024-01-01 Mastorino, Luca; Richiardi, Irene; Gelato, Federica; Cavaliere, Giovanni; Quaglino, Pietro; Ortoncelli, Michela; Ribero, Simone
Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected Melanoma
2024-01-01 Roccuzzo, Gabriele; Fava, Paolo; Astrua, Chiara; Brizio, Matteo Giovanni; Cavaliere, Giovanni; Bongiovanni, Eleonora; Santaniello, Umberto; Carpentieri, Giulia; Cangiolosi, Luca; Brondino, Camilla; Pala, Valentina; Ribero, Simone; Quaglino, Pietro
Risankizumab-induced red face: a unique presentation
2024-01-01 ROCCUZZO, Gabriele; GIORDANO, Silvia; BONGIOVANNI, Eleonora; GIUNIPERO DI CORTERANZO, Isotta; CAVALIERE, Giovanni; MASTORINO, Luca; QUAGLINO, Pietro; RIBERO, Simone
Safety of dupilumab in patients with cancer
2024-01-01 Macagno, Nicole; Mastorino, Luca; Siliquini, Niccolò; Santaniello, Umberto; Gelato, Federica; Cavaliere, Giovanni; Ortoncelli, Michela; Ribero, Simone; Quaglino, Pietro
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A traveller's wart: tungiasis | 2018 | Fava, Paolo; Astrua, Chiara; Brizio, Matteo; Cavaliere, Giovanni; Senetta, Rebecca; Fierro, Maria Teresa; Quaglino, Pietro | |
| Chronic Pruritus in Atopic Patients Treated with Dupilumab: Real Life Response and Related Parameters in 354 Patients | 2022 | Mastorino, Luca; Rosset, François; Gelato, Federica; Ortoncelli, Michela; Cavaliere, Giovanni; Quaglino, Pietro; Ribero, Simone | |
| Complete regression of melanoma skin metastases after electrochemotherapy plus ipilimumab treatment: An unusual clinical presentation | 2015 | Brizio, Matteo; Fava, Paolo; Astrua, Chiara; Cavaliere, Giovanni; Savoia, Paola | |
| Dermatological approach to vemurafenib skin toxicity: a single centre experience | 2016 | Fava, Paolo; Marra, Elena; Astrua, Chiara; Brizio, Matteo; Cavaliere, Giovanni; Quaglino, Pietro; Fierro, Maria T; Savoia, Paola | |
| Dose reduction of dupilumab in atopic patients with controlled atopic dermatitis: A safe and effective practice? | 2023 | Mastorino, Luca; Gelato, Federica; Richiardi, Irene; Cavaliere, Giovanni; Quaglino, Pietro; Ortoncelli, Michela; Ribero, Simone | |
| Dupilumab induces a rapid decrease of pruritus in adolescents: A pilot real-life study | 2021 | Mastorino L.; Viola R.; Panzone M.; Avallone G.; Gallo G.; Ortoncelli M.; Cavaliere G.; Quaglino P.; Ribero S. | |
| Epidemiologia, diagnosi clinica e patologica | 2018 | Pietro QUaglino, Giovanni Cavaliere, Rebecca Senetta, Simone Ribero, Franco PIcciotto | |
| Herpes Zoster Infection in Atopic Patients Undergoing Upadacitinib: Practical Suggestions on Vaccination and Management | 2023 | Ortoncelli, Michela; Mastorino, Luca; Gelato, Federica; Richiardi, Irene; Cavaliere, Giovanni; Quaglino, Pietro; Ribero, Simone | |
| Identification of risk factors for multiple non-melanoma skin cancers in italian kidney transplant recipients | 2019 | Zavattaro E.; Fava P.; Veronese F.; Cavaliere G.; Ferrante D.; Cantaluppi V.; Ranghino A.; Biancone L.; Fierro M.T.; Savoia P. | |
| Impact of comorbidities in the response of atopic patients treated with dupilumab: a real-life study up to 36 weeks | 2022 | Mastorino, L; Cantafio Duò, V L; Vecco, C; Gelato, F; Giordano, S; Roccuzzo, G; Cavaliere, G; Avallone, G; Ortoncelli, M; Ribero, S; Quaglino, P | |
| Intestinal involvement in toxic epidermal necrolysis. A case report and review of literature. | 2014 | Fava, P; Astrua, C; Cavaliere, G; Brizio, M; Savoia, P; Quaglino, P; Fierro, Mt1. | |
| Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis? | 2023 | Gelato, Federica; Mastorino, Luca; Stepkina, Ekaterina; Cavaliere, Giovanni; Ribero, Simone; Quaglino, Pietro; Ortoncelli, Michela | |
| Long-Term Efficacy and Safety of Dupilumab in Patients with Atopic Dermatitis: A Single-Centre Retrospective Study | 2023 | Ortoncelli, M; Macagno, N; Mastorino, L; Gelato, F; Richiardi, I; Cavaliere, G; Quaglino, P; Ribero, S | |
| Mogamulizumab associated crusted scabies: a rare diagnostic confounder | 2024 | GIUNIPERO DI CORTERANZO, Isotta; ROCCUZZO, Gabriele; CRESPI, Orsola; CAVALIERE, Giovanni; FAVA, Paolo; RIBERO, Simone; QUAGLINO, Pietro | |
| Ocular Adverse Events in Patients With Atopic Dermatitis Treated With Upadacitinib: A Real-Life Experience | 2023 | Gelato, Federica; Mastorino, Luca; Quaglino, Pietro; Cavaliere, Giovanni; Ortoncelli, Michela; Ribero, Simone | |
| Onset of multiple sclerosis in a patient on dupilumab therapy for atopic dermatitis: A case report | 2022 | Gelato, Federica; Mastorino, Luca; Cavalla, Paola; Quaglino, Pietro; Cavaliere, Giovanni; Vercellino, Marco; Bosa, Chiara; Inglese, Matilde; De Palma, Raffaele; Ortoncelli, Michela; Ribero, Simone | |
| Predisposition to conjunctivitis and male sex reduces drug survival of dupilumab in adults and adolescents | 2024 | Mastorino, Luca; Richiardi, Irene; Gelato, Federica; Cavaliere, Giovanni; Quaglino, Pietro; Ortoncelli, Michela; Ribero, Simone | |
| Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected Melanoma | 2024 | Roccuzzo, Gabriele; Fava, Paolo; Astrua, Chiara; Brizio, Matteo Giovanni; Cavaliere, Giovanni; Bongiovanni, Eleonora; Santaniello, Umberto; Carpentieri, Giulia; Cangiolosi, Luca; Brondino, Camilla; Pala, Valentina; Ribero, Simone; Quaglino, Pietro | |
| Risankizumab-induced red face: a unique presentation | 2024 | ROCCUZZO, Gabriele; GIORDANO, Silvia; BONGIOVANNI, Eleonora; GIUNIPERO DI CORTERANZO, Isotta; CAVALIERE, Giovanni; MASTORINO, Luca; QUAGLINO, Pietro; RIBERO, Simone | |
| Safety of dupilumab in patients with cancer | 2024 | Macagno, Nicole; Mastorino, Luca; Siliquini, Niccolò; Santaniello, Umberto; Gelato, Federica; Cavaliere, Giovanni; Ortoncelli, Michela; Ribero, Simone; Quaglino, Pietro |